Clear Aligners for the Treatment of Dental Malocclusion in OI

Description

Misalignment of teeth and jaws (also called malocclusion) is a common life altering problem facing many individuals with Osteogenesis Imperfecta (OI). The presence of Dentinogenesis Imperfecta in teeth of OI individuals makes the use of conventional orthodontics in the form of braces very challenging. Clear aligners are newer form of orthodontic treatment and is less invasive than braces. Therefore, the aim of our study is to evaluate the efficiency and safety of using Invisalign clear aligners for orthodontic treatment in individuals with Osteogenesis Imperfecta. We seek individual with Osteogenesis Imperfecta, with mild to moderate malocclusion and no prior history of orthodontic treatment. This study will be held at three sites - McGill University, University of California Los Angeles and National Institute of Dental and Craniofacial research. This study will for the first time, help define guidelines for safe and efficient orthodontic treatment using clear aligners in individuals with Osteogenesis Imperfecta. If successful, this approach can rapidly be implemented into clinical practice, as the Invisalign system is readily available to orthodontists.

Conditions

Osteogenesis Imperfecta

Talk to us

Study Overview

On this page

Study Details

Study overview

Misalignment of teeth and jaws (also called malocclusion) is a common life altering problem facing many individuals with Osteogenesis Imperfecta (OI). The presence of Dentinogenesis Imperfecta in teeth of OI individuals makes the use of conventional orthodontics in the form of braces very challenging. Clear aligners are newer form of orthodontic treatment and is less invasive than braces. Therefore, the aim of our study is to evaluate the efficiency and safety of using Invisalign clear aligners for orthodontic treatment in individuals with Osteogenesis Imperfecta. We seek individual with Osteogenesis Imperfecta, with mild to moderate malocclusion and no prior history of orthodontic treatment. This study will be held at three sites - McGill University, University of California Los Angeles and National Institute of Dental and Craniofacial research. This study will for the first time, help define guidelines for safe and efficient orthodontic treatment using clear aligners in individuals with Osteogenesis Imperfecta. If successful, this approach can rapidly be implemented into clinical practice, as the Invisalign system is readily available to orthodontists.

Use of Clear Aligners for the Treatment of Dental Malocclusion in Individuals With Osteogenesis Imperfecta

Clear Aligners for the Treatment of Dental Malocclusion in OI

Condition
Osteogenesis Imperfecta
Intervention / Treatment

-

Contacts and Locations

Los Angeles

University of California Los Angeles, Los Angeles, California, United States, 90095

Bethesda

Nidcr/Nih, Bethesda, Maryland, United States, 20892-1470

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Clinical diagnosis of OI.
  • 2. Malocclusion of intermediate severity defined as a PAR score between 15 and 50.
  • 3. Age range 12 to 40 years at the screening visit.
  • 4. Presence of minimum number of intact teeth to proceed with orthodontic treatment.
  • 1. Prior orthodontic treatment defined as - any history of braces, palatal expansion or Invisalign treatment.
  • 2. Candidates who meet the PAR score but need surgical intervention for correction of malocclusion
  • 3. Presence of impacted or retained teeth.
  • 4. Use of medication, other than bisphosphonates, known to affect bone metabolism and contraindicated on orthodontic treatment, examples are, growth hormone, corticosteroids (chronic use) and thyroid hormones.
  • 5. Presence of other dental, oral or systemic conditions that may interfere with orthodontic treatment. Examples are severe gingivitis, active periodontal disease, cancer.
  • 6. Pregnancy - positive during screening visit.

Ages Eligible for Study

12 Years to 40 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Baylor College of Medicine,

Janice Lee, PRINCIPAL_INVESTIGATOR, NIDCR/NIH

Jean-Marc Retrouvey, PRINCIPAL_INVESTIGATOR, Baylor College of Medicine

Deborah Krakow, PRINCIPAL_INVESTIGATOR, University of California, Los Angeles

Julia Cohen-Levy, PRINCIPAL_INVESTIGATOR, McGill University

Study Record Dates

2026-07